News

Marco Investment Management Has Lowered Holding in Amgen (AMGN) by $2.68 Million as Stock Value Declined; Horrell Capital Management Has Lowered Juniper Networks (JNPR) Holding by $1.45 Million as Stock Price Declined

[ad_1]

Amgen Inc. (NASDAQ:AMGN) Logo

Horrell Capital Management Inc decreased its stake in Juniper Networks (JNPR) by 26.04% based on its latest 2018Q3 regulatory filing with the SEC. Horrell Capital Management Inc sold 50,000 shares as the company’s stock declined 0.07% with the market. The institutional investor held 142,000 shares of the technology company at the end of 2018Q3, valued at $4.26M, down from 192,000 at the end of the previous reported quarter. Horrell Capital Management Inc who had been investing in Juniper Networks for a number of months, seems to be less bullish one the $9.01B market cap company. The stock increased 0.46% or $0.12 during the last trading session, reaching $26.09. About 2.71M shares traded. Juniper Networks, Inc. (NYSE:JNPR) has declined 2.85% since February 9, 2018 and is downtrending. It has underperformed by 2.85% the S&P500. Some Historical JNPR News: 09/03/2018 – Eucom: U.S. European commander visits troops participating in Juniper Cobra 2018; 23/03/2018 – JUNIPER NETWORKS NAMES MANOJ LEELANIVAS CHIEF PRODUCT OFFICER; 11/05/2018 – Juniper Networks Announces Date and Webcast Information for Upcoming Investor Conference for June 2018; 23/03/2018 – Juniper Networks Strengthens Leadership Team; 03/04/2018 – New Securematics and PureWRX Partnership Accelerates Adoption of Juniper Certified Pre-Owned Hardware; 30/04/2018 – Juniper at Bernstein Strategic Decisions CEO Conference May 30; 15/05/2018 – Juniper Presenting at JPMorgan Conference Tomorrow; 01/05/2018 – JUNIPER SEES 2Q ADJ EPS 44C, +/- 3C, EST. 43C; 14/05/2018 – Juniper Research: Enterprise Mixed Reality Applications to Approach 40 Million by 2022, as App Revenues Near $6 Billion; 23/03/2018 – Juniper Networks: Names Manoj Leelanivas as Executive Vice Pres, Chief Pdt Officer

Marco Investment Management Llc decreased its stake in Amgen Inc (AMGN) by 10.91% based on its latest 2018Q3 regulatory filing with the SEC. Marco Investment Management Llc sold 12,936 shares as the company’s stock declined 4.15% with the market. The institutional investor held 105,665 shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $21.90M, down from 118,601 at the end of the previous reported quarter. Marco Investment Management Llc who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $117.18 billion market cap company. The stock increased 0.96% or $1.77 during the last trading session, reaching $186. About 2.60M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 11.57% since February 9, 2018 and is uptrending. It has outperformed by 11.57% the S&P500. Some Historical AMGN News: 01/05/2018 – Sanofi/Regeneron’s one-two punch on PCSK9 price and health data wins a key convert as Express Scripts creates exclusive formulary deal $REGN $SNY $AMGN $ESRX; 18/04/2018 – #2 Blockbuster ambitions: Amgen/Novartis team lines up more promising PhIII erenumab data for some of the toughest migraine patients $AMGN $NVS; 23/03/2018 – Amgen, Allergan Get Positive CHMP Opinion for Biosimilar Herceptin for Three Types of Cancer; 24/04/2018 – AMGEN 1Q REPATHA REV. $123M, EST. $104.7M; 21/05/2018 – AMGEN INC – SAFETY RESULTS WERE CONSISTENT WITH KNOWN SAFETY PROFILE OF PROLIA; 17/05/2018 – FDA Approves Anti-migraine Drug From Novartis, Amgen — MarketWatch; 05/04/2018 – AbbVie in deal with Biogen to delay Humira biosimilar U.S. launch to 2023; 01/05/2018 – The deal excludes a competing medicine made by Amgen from Express Scripts’ National Preferred Formulary Plan; 18/05/2018 – Prolia (denosumab; Amgen/Daiichi Sankyo) Drug Overview 2018 – ResearchAndMarkets.com; 29/03/2018 – CORVIDIA THERAPEUTICS APPOINTS MARC DE GARIDEL AS CHIEF EXECUTIVE OFFICER

Marco Investment Management Llc, which manages about $888.82 million and $702.49 million US Long portfolio, upped its stake in Broadcom Inc by 18,055 shares to 29,545 shares, valued at $7.29M in 2018Q3, according to the filing. It also increased its holding in Intel Corp (NASDAQ:INTC) by 32,719 shares in the quarter, for a total of 370,455 shares, and has risen its stake in Micron Technology Inc (NASDAQ:MU).

Since November 29, 2018, it had 0 buys, and 2 sales for $4.27 million activity. Jacks Tyler also sold $3.91 million worth of Amgen Inc. (NASDAQ:AMGN) shares.

Investors sentiment decreased to 0.87 in Q3 2018. Its down 0.12, from 0.99 in 2018Q2. It worsened, as 49 investors sold AMGN shares while 550 reduced holdings. 130 funds opened positions while 393 raised stakes. 470.42 million shares or 2.68% less from 483.36 million shares in 2018Q2 were reported. 13,965 were accumulated by Pioneer Trust Commercial Bank N A Or. Scott And Selber reported 15,249 shares. Pettyjohn Wood White reported 0.21% stake. Moreover, Amer Research And Mgmt has 0.29% invested in Amgen Inc. (NASDAQ:AMGN) for 4,677 shares. Colonial Tru reported 2,040 shares. The Georgia-based Vident Advisory Llc has invested 0.04% in Amgen Inc. (NASDAQ:AMGN). 4,587 were accumulated by Camarda Advsr Llc. Financial Counselors reported 85,805 shares or 0.78% of all its holdings. Norinchukin Bancshares The holds 116,391 shares. Altfest L J And invested 0.3% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Wellington Grp Limited Liability Partnership has 0.23% invested in Amgen Inc. (NASDAQ:AMGN). Peapack Gladstone Corp owns 0.71% invested in Amgen Inc. (NASDAQ:AMGN) for 69,732 shares. California State Teachers Retirement System has invested 0.46% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Hartford Mngmt Com holds 0.49% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 80,143 shares. Howland Management Ltd Liability accumulated 0.03% or 2,014 shares.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Amgen Earnings: AMGN Stock Slips on Q4 Earnings Beat, Weak Q1 Guidance – Nasdaq” on January 29, 2019, also Nasdaq.com with their article: “Health Care Sector Update for 01/29/2019: ARAY, TRVN, ABBV, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” published on January 29, 2019, Finance.Yahoo.com published: “The Daily Biotech Pulse: FDA Panel Backs Amgen’s Hypertension Drug, Adamis Allergy Drug Launched In US – Yahoo Finance” on January 17, 2019. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Seekingalpha.com and their article: “Expanded use for Amgen’s Blincyto OK’d in Europe – Seeking Alpha” published on January 22, 2019 as well as Nasdaq.com‘s news article titled: “Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” with publication date: January 16, 2019.

Among 28 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 17 Hold. Therefore 39% are positive. Amgen Inc. had 102 analyst reports since August 3, 2015 according to SRatingsIntel. The company was downgraded on Monday, January 28 by Evercore. The firm earned “Hold” rating on Monday, February 5 by Atlantic Securities. The rating was maintained by Barclays Capital on Thursday, April 5 with “Equal-Weight”. Atlantic Securities initiated Amgen Inc. (NASDAQ:AMGN) on Friday, December 18 with “Overweight” rating. As per Wednesday, July 26, the company rating was maintained by UBS. The stock of Amgen Inc. (NASDAQ:AMGN) has “Outperform” rating given on Friday, July 31 by RBC Capital Markets. The firm has “Buy” rating given on Monday, September 7 by UBS. The rating was maintained by Citigroup on Monday, July 30 with “Neutral”. The company was maintained on Wednesday, July 12 by Oppenheimer. The firm earned “Market Perform” rating on Friday, February 2 by BMO Capital Markets.

More notable recent Juniper Networks, Inc. (NYSE:JNPR) news were published by: Seekingalpha.com which released: “Juniper Networks -6.2% on light Q3 guidance – Seeking Alpha” on July 26, 2018, also Seekingalpha.com with their article: “Using Ratios To Identify Stocks Set To Outperform Their Peers: Statistical Summary Of 2 Years Of Research – Seeking Alpha” published on February 06, 2019, Seekingalpha.com published: “Premarket analyst action – Seeking Alpha” on September 26, 2018. More interesting news about Juniper Networks, Inc. (NYSE:JNPR) were released by: Seekingalpha.com and their article: “Juniper Networks +3.3% after Q3 tops profit consensus – Seeking Alpha” published on October 23, 2018 as well as Globenewswire.com‘s news article titled: “Juniper Networks Expands Partnership with Ericsson to Accelerate 5G Transformation – GlobeNewswire” with publication date: September 05, 2018.

Investors sentiment decreased to 0.91 in Q3 2018. Its down 0.01, from 0.92 in 2018Q2. It dived, as 31 investors sold JNPR shares while 137 reduced holdings. 48 funds opened positions while 105 raised stakes. 305.23 million shares or 0.61% less from 307.11 million shares in 2018Q2 were reported. American Century Cos holds 155,850 shares or 0% of its portfolio. Sumitomo Mitsui Asset Management Ltd owns 23,621 shares. Amg Funds Ltd owns 67,582 shares or 1.48% of their US portfolio. 20,200 were reported by Oppenheimer & Com. Moreover, Vident Advisory Limited Liability has 0.02% invested in Juniper Networks, Inc. (NYSE:JNPR). Bluemountain Limited Company invested in 118,806 shares or 0.06% of the stock. Price T Rowe Assoc Inc Md, Maryland-based fund reported 1.93M shares. Janney Montgomery Scott Limited Liability Company holds 9,398 shares. Sei Invests invested 0.02% of its portfolio in Juniper Networks, Inc. (NYSE:JNPR). Cibc World Corporation invested 0.02% in Juniper Networks, Inc. (NYSE:JNPR). Meeder Asset Mgmt Incorporated stated it has 120,310 shares or 0.27% of all its holdings. Moreover, Jpmorgan Chase has 0.01% invested in Juniper Networks, Inc. (NYSE:JNPR) for 1.50 million shares. British Columbia Invest holds 0.04% or 113,056 shares. Moreover, Raymond James Fin Advsrs has 0% invested in Juniper Networks, Inc. (NYSE:JNPR). Savings Bank Of New York Mellon Corp reported 6.70 million shares.

Among 36 analysts covering Juniper Networks Inc. (NYSE:JNPR), 8 have Buy rating, 9 Sell and 19 Hold. Therefore 22% are positive. Juniper Networks Inc. had 109 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Juniper Networks, Inc. (NYSE:JNPR) earned “Perform” rating by Oppenheimer on Tuesday, January 5. On Wednesday, May 2 the stock rating was upgraded by Deutsche Bank to “Hold”. The stock has “Neutral” rating by Citigroup on Tuesday, October 6. UBS maintained Juniper Networks, Inc. (NYSE:JNPR) rating on Friday, July 24. UBS has “Buy” rating and $32 target. The firm has “Outperform” rating by Credit Suisse given on Wednesday, December 7. The stock of Juniper Networks, Inc. (NYSE:JNPR) earned “Outperform” rating by RBC Capital Markets on Wednesday, January 20. The stock of Juniper Networks, Inc. (NYSE:JNPR) has “Neutral” rating given on Wednesday, January 31 by Nomura. The firm earned “Outperform” rating on Friday, January 29 by Bernstein. The firm has “Buy” rating by Nomura given on Thursday, December 8. The rating was downgraded by Bernstein on Tuesday, January 5 to “Mkt Perform”.

Since August 22, 2018, it had 0 insider purchases, and 5 sales for $4.89 million activity. $3.36M worth of Juniper Networks, Inc. (NYSE:JNPR) was sold by Athreya Anand. rahim rami also sold $488,676 worth of Juniper Networks, Inc. (NYSE:JNPR) on Wednesday, November 7. On Wednesday, January 30 Koley Bikash sold $177,525 worth of Juniper Networks, Inc. (NYSE:JNPR) or 7,101 shares.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

[ad_2]

Source link